Coronary Flow Velocity Reserve by Stress Echocardiography: The Prognostic Key of Multiple Heart Diseases.
- 1Servicio Cardiodiagnóstico, Investigaciones Medicas, Buenos Aires C1056ABA, Argentina.
Abstract
Although evaluating coronary flow velocity reserve (CFVR) via stress echocardiography (SE) has been available for over three decades, its integration into routine clinical practice remains underutilized globally despite substantial technical and conceptual advances. A diminished CFVR serves as a potent predictor of major adverse cardiovascular events (MACE) and all-cause mortality across a broad spectrum of cardiovascular diseases. Its prognostic value is particularly robust in epicardial coronary artery disease, heart failure, coronary microvascular dysfunction, nonischemic cardiomyopathies, metabolic disorders (e.g., diabetes mellitus and obesity), hypertrophic cardiomyopathy, systemic autoimmune diseases, and cardiac allograft vasculopathy. This comprehensive narrative review details the technical methodology for interrogating resting and stress-induced coronary flow velocity (CFV) under physical and pharmacological protocols. Furthermore, it highlights the clinical applicability of CFVR by synthesizing single-center observational insights with evidence from large-scale multicenter registries, advocating for its broader adoption into diagnostic workflows to refine risk stratification and guide therapeutic management.
Related
- Acute Changes in Left Atrial Appendage Flow Velocity During Pulsed Field Ablation: An Intraprocedural Intracardiac Echocardiography Study
- Stress Echocardiography Beyond Wall Motion in ANOCA/INOCA: Coronary Microvascular Dysfunction and Multiparametric Assessment
- Prognostic Impact of Left Ventricular Apical Aneurysm Identified by Echocardiography in Hypertrophic Cardiomyopathy ― A Multicenter Retrospective Study in Japan ―
- Fully Automated Multi-Chamber Strain Profiling in Consecutive Patients Undergoing Transthoracic Echocardiography: Feasibility, Functional Clustering, and Prognostic Implications
- Prognostic Value of Plaque Burden Beyond Stenosis Severity in Patients with Stable Chest Pain Undergoing Coronary CT Angiography
BibTeX
@article{lowenstein2026coronary,
title = {{Coronary Flow Velocity Reserve by Stress Echocardiography: The Prognostic Key of Multiple Heart Diseases.}},
author = {Jorge Lowenstein},
journal = {Diagnostics (Basel, Switzerland)},
year = {2026},
month = oct,
doi = {10.3390/diagnostics16193256},
url = {https://europepmc.org/article/MED/42882411},
note = {CC BY},
}
RIS
TY - JOUR
TI - Coronary Flow Velocity Reserve by Stress Echocardiography: The Prognostic Key of Multiple Heart Diseases.
AU - Jorge Lowenstein
PY - 2026
DA - 2026/10/08
JO - Diagnostics (Basel, Switzerland)
DO - 10.3390/diagnostics16193256
UR - https://europepmc.org/article/MED/42882411
AB - Although evaluating coronary flow velocity reserve (CFVR) via stress echocardiography (SE) has been available for over three decades, its integration into routine clinical practice remains underutilized globally despite substantial technical and conceptual advances. A diminished CFVR serves as a potent predictor of major adverse cardiovascular events (MACE) and all-cause mortality across a broad spectrum of cardiovascular diseases. Its prognostic value is particularly robust in epicardial coronary artery disease, heart failure, coronary microvascular dysfunction, nonischemic cardiomyopathies, metabolic disorders (e.g., diabetes mellitus and obesity), hypertrophic cardiomyopathy, systemic autoimmune diseases, and cardiac allograft vasculopathy. This comprehensive narrative review details the technical methodology for interrogating resting and stress-induced coronary flow velocity (CFV) under physical and pharmacological protocols. Furthermore, it highlights the clinical applicability of CFVR by synthesizing single-center observational insights with evidence from large-scale multicenter registries, advocating for its broader adoption into diagnostic workflows to refine risk stratification and guide therapeutic management.
SN - 2075-4418
ER -